Director, Value, Access & Pricing- US Rare Tumors; TGCT

About Spring Works Therapeutics

Spring Works Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company dedicated to improving the lives of patients with rare tumors. We developed and are commercializing the first and only FDA and EC approved medicine for adults with desmoid tumors and the first and only FDA and EC approved medicine for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN).

At Spring Works, we are committed to finding answers people with rare tumors need. We thrive in an atmosphere of passion and tenacity, fueled by the excitement of the possibilities science may unlock and driven to work with urgency because of the importance of our work. We value authenticity because diverse backgrounds, cultures, styles and abilities can only help us find the answers that people with rare tumors are looking for.

The Director, Value, Access & Pricing (VAP) is a critical leadership role within the U.S. Market Access team, responsible for shaping the strategic direction and leading the development and execution of market access and pricing strategies to support the commercial success of pimicotinib for TGCT. This individual will lead the development of access strategies and tactics that communicate the differentiated value of pimicotinib to key external stakeholders—including payers, C-suite executives, provider networks, GPOs, pharmacists, and population-based decision-makers in community oncology.

The Director will be accountable for delivering a suite of payer and provider-facing tools, field team resources, and non-personal engagement tactics to ensure optimal access and uptake. The Director will work in close partnership with the broader U.S. Market Access and collaborate closely with cross-functional partners including brand marketing, sales, HEOR, medical affairs, patient services, and operations to ensure strategic alignment and execution excellence.

This role will be required to work onsite 3 days a week or more as business needs require.

• Act as the product-specific market access expert and central hub for all access‑related topics, serving as the primary point of contact for cross‑functional teams and informing the broader U.S. Market Access organization on product-specific developments, strategies, and insights
• Leads the development of Market Access strategies and evidence‑based payor value proposition; manages the execution of brand‑aligned Market Access tactical plans that influence coverage decisions and remove patient access hurdles
• Leads strategic and tactical development and pull through of various field‑based resources to support field facing teams including Strategic Enterprise Account Directors (SEADs), Field Access Managers (FAMs), and Sales teams
• Shapes the development of pricing and contracting strategies, ensuring market competitiveness, payor acceptance and coverage policies that enable patient access
• Manage Pricing and Government Pricing annual lifecycle, including both strategic and operational activities to maintain compliance with regulations
• Continuously evaluates changing market and competitive dynamics to inform short and long‑term strategies including but not limited to formulary positioning, contracting, pricing, real‑world evidence generation and public policy
• Leads the management of key strategic partner relationships to ensure execution of the strategic vision and tactical goals as well as the timely completion of projects within budget
• Monitor evolving reimbursement and policy landscape and integrate insights into access strategy
• Measure and report impact of targeted launch / access tactical plan investments

Bachelor's degree (business or related disciplines)

• Bachelor's degree (business or related disciplines)
• MBA or other advanced degree preferred

• 9+ years of pharmaceutical and/or biotech experience required in rare disease or Oncology
• 5+ years in internal Market access role
• Internal rare disease/oncology launch experience required (strategic,…